EUVIMEDEUVIMED entdecken
Fallbericht

Challenge of Diagnostic Criteria for Diffuse Hemispheric Glioma (DHG), H3 G34‐Mutant: A Case of DHG Without H3.3 Gene Alteration

Tianran Hu, Xiaojia Liu, Yang Lan, Jia Ge, Lihong Wang, Jiao Wang, Sen Wei, Hong Chen, Tao Luo iD

Neuropathology and Applied Neurobiology · 2026-04 · 52 (2)

DOI: 10.1111/nan.70073 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 06.04.2026. Verfasst von Tianran Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laborator…. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Histones. Die Arbeit nennt 8 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present a case of diffuse hemispheric glioma (DHG), H3 G34‐mutant, NEC. Postoperative histological examination and DNA sequencing detected some features consistent with DHG, H3 G34‐mutant; however, no canonical H3 alterations or ATRX variants were detected. The diagnosis could only be established based on the DNA methylation profiling result. In light of these distinctive molecular findings, we propose some insights into the current WHO diagnostic criteria for DHG H3‐G34 and emphasise the value of comprehensive molecular diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaHistonesHumansDNA MethylationMutation

Stichwörter der Autor:innen

DNA methylation profilingH3 G34‐mutantWHO diagnostic criteriadiffuse hemispheric glioma

Substanzen

Histones

Autor:innen und Institutionen

  • Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing,…
  • Department of Pathology, Huashan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Tao Luo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hu, T., Liu, X., Lan, Y., Ge, J., Wang, L., Wang, J., Wei, S., Chen, H., & Luo, T. (2026). Challenge of Diagnostic Criteria for Diffuse Hemispheric Glioma (DHG), H3 G34‐Mutant: A Case of DHG Without H3.3 Gene Alteration. Neuropathology and Applied Neurobiology, 52(2). https://doi.org/10.1111/nan.70073

Vancouver

Hu T, Liu X, Lan Y, Ge J, Wang L, Wang J, et al. Challenge of Diagnostic Criteria for Diffuse Hemispheric Glioma (DHG), H3 G34‐Mutant: A Case of DHG Without H3.3 Gene Alteration. Neuropathology and Applied Neurobiology. 2026;52(2). doi:10.1111/nan.70073

BibTeX
@article{Hu2026,
  author = {Hu, Tianran and Liu, Xiaojia and Lan, Yang and Ge, Jia and Wang, Lihong and Wang, Jiao and Wei, Sen and Chen, Hong and Luo, Tao},
  title = {Challenge of Diagnostic Criteria for Diffuse Hemispheric Glioma (DHG), H3 G34‐Mutant: A Case of DHG Without H3.3 Gene Alteration},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2026},
  volume = {52},
  number = {2},
  doi = {10.1111/nan.70073}
}
Kostenlos starten →